Skip to content

Comparison of Two Robotic-Assisted Total Knee Arthroplasty Systems

Prospective, Randomized, Single-center Study Comparing the Stryker MAKO™ Robotic-Arm Assisted Total Knee Arthroplasty and the DePuy VELYS™ Robotic-Assisted Solution for Total Knee Arthroplasty.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06284824
Enrollment
120
Registered
2024-02-29
Start date
2024-05-31
Completion date
2027-05-31
Last updated
2024-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Arthritis, Knee Disease, Knee Osteoarthritis

Keywords

robotic assistance, arthroplasty, TKA

Brief summary

The goal of this prospective study is to compare two different knee replacement robots. This study will look at patient reported outcome measures and data collected during the operation. The main questions this study aims to answer include: * Will the patient reported outcomes differ between the two groups? * Will the intraoperative data differ between the two groups? Participants will undergo total knee replacement with one of the two robots, complete standardized surveys, and have x-rays taken.

Detailed description

The purpose of this study is to compare two different total knee arthroplasty (TKA) robotic assisted (RA) devices. This study will compare patient reported outcome measures prior to and after surgery. These surveys will be used determine if there are differences in patient recovery after TKA depending on the robot used. Radiographs will also be taken and used to compare component positioning. Intraoperative data will be collected to compare OR efficiency of the two systems.

Interventions

DEVICEStryker Triathlon with MAKO Robotic-Arm

Implant is the Stryker Triathlon total knee arthroplasty and the robotic device is the MAKO robotic-arm

DEVICEDePuy Attune with VELYS Robotic-Assistance

Implant is the DePuy Attune total knee arthroplasty and the robotic device is the VELYS robotic-assistance

Sponsors

DePuy Orthopaedics
CollaboratorINDUSTRY
Stryker Orthopaedics
CollaboratorINDUSTRY
Southeast Orthopedic Specialists
Lead SponsorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patient must be a candidate for primary TKA (either Stryker Triathlon with MAKO Robotic-Arm or DePuy Attune with VELYS Robotic-Assistance). * Individuals who are able to speak, read, and comprehend the Institutional Review Board approved Informed Consent Document and willing and able to provide informed patient consent for participation in the study and have authorized the transfer of information to the Sponsor. * Individuals who are willing and able to complete follow up visits, questionnaires, and radiographic evaluations as specified by the study protocol. * Individuals who are male or non-pregnant female age 18-80 years at time of device implantation. * Patient has a diagnosis of primary osteoarthritis or degenerative joint disease of the knee.

Exclusion criteria

* Patient has a Body Mass Index (BMI) \> 40. * Patient has been diagnosed with osteoporosis or displays poor bone quality per the discretion of the investigator. * Patient has an active or suspected latent infection in affected knee joint. Patient has neuromuscular or neurosensory deficiency. * Patient is diagnosed with systemic disease or metabolic disorder (e.g., Lupus, Charcot's. Paget's). * Subject is a woman who is pregnant or lactating. * Patient has a contralateral amputation. * Patient's affected knee has a flexion contracture greater than 15 degrees. * Patient has history of post operative arthrofibrosis. * Patient's affected knee has a partial knee arthroplasty. * Patient has undergone contralateral TKA within the last three months. * Patient is currently involved in any personal injury litigation, medical-legal, or worker's compensation claims. * Patient who is bedridden per the discretion of the investigator. * Patient has a medical condition with less than 2 years of life expectancy.

Design outcomes

Primary

MeasureTime frameDescription
KSSbaselineKnee Society Score
KOOS JRbaselineKnee injury and Osteoarthritis Outcome Score for Joint Replacement
FJS-12 Knee6 weekForgotten Joint Score

Secondary

MeasureTime frameDescription
Operative step timeIntraoperativeTiming for use of robot during surgery

Other

MeasureTime frameDescription
Bone resectedIntraoperativeAmount of bone resected
Costs for surgeryImmediate post operativeFactors associated with insurance costs for surgery

Contacts

Primary ContactAlexis Velez, BS
alexisavelez@gmail.com13214439922
Backup ContactJohn Redmond, MD
john.redmond@live.com9043286711

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026